USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences Market Research Reports
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
20 Apr 2023 | Asia Pacific | Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $4,455.00 save 10 %
-
05 Apr 2023 | Asia Pacific | Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japa...
$4,950.00
Special Price $4,455.00 save 10 %
-
12 Nov 2018 | Asia Pacific | Market Research
Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021
Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country
Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...
$1,500.00
Special Price $1,125.00 save 25 %
-
10 Jan 2018 | Asia Pacific | Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Dec 2015 | Asia Pacific | Market Research
Analysis of the Medical Imaging Market in Selected ASEAN Countries
Growth and Trends in CT, MR, PET, and SPECT Modalities
This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...
$6,000.00
Special Price $4,500.00 save 25 %
-
08 Dec 2015 | Asia Pacific | Market Research
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...
$6,000.00
Special Price $4,500.00 save 25 %
-
11 Nov 2015 | Asia Pacific | Market Research
Asia-Pacific Point-of-Care Testing Market
Trends, Challenges, and Best Practices for Stakeholders
Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Oct 2015 | Asia Pacific | Market Research
Asia-Pacific Regulations Driving Innovation in Healthcare
Innovative Public-Private Initiatives Attracting Investment in Research & Development
The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Sep 2015 | Asia Pacific | Market Research
End-User Perspectives on the SEA RIS/ PACS Market
Next-generation Imaging IT Needs Will Focus on Interoperability
Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Sep 2015 | Asia Pacific | Market Research
Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020
Policies Raising Standards and Lowering Barriers Across ASEAN
The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...
$2,450.00
Special Price $1,837.50 save 25 %
